INDV - indivior.com Annual Revenue Growth (Last Twelve Months)

The rolling annual sales growth rate demonstrates the resilience of Indivior PLC (INDV), a pioneer in opioid addiction therapy with a protected Sublocade market. The value of 16.40 characterizes this level, highlighting the effectiveness of R&D in developing long-acting injections for the treatment of schizophrenia. The company's strategic vector relies on close cooperation with government agencies and the medical community to eradicate addictions.
Summary analytical data breakdowns for Indivior (INDV)

This metric measures revenue dynamics over the last twelve months, neutralizing seasonal fluctuations to identify the true trajectory of business development. By analyzing the current year-over-year revenue growth (TTM), an investor assesses the company's ability to scale sales in real time. For Indivior PLC (INDV), the stability of this trend is ensured by the humanitarian status of its drugs and the localization of production facilities. The absence of geopolitical risks makes the asset's fundamental growth predictable.